New Enterprise Associates
http://www.nea.com/Home/New Enterprise Associates is a venture capital firm based in Baltimore, MD. The firm has backed more than 160 companies that have gone public and invested in more than 230 companies that have been successfully merged or acquired. NEA focuses its investments in the information technology, healthcare, and energy technology industries. While NEA makes a majority of its investments in the United States, the firm invests around the world in China and India. The firm was founded in 1978.
View Older Stories View More Recent Stories
-
Parity.org Launches ParityPledge in Support of People of Color
-
Verona Pharma plc (VRNA) Raises $200 Million in Oversubscribed Private Placement and Subscription
-
Verona Pharma Raises $200 Million in Oversubscribed Private Placement and Subscription
-
Verona Pharma Raises $200 Million in Oversubscribed Private Placement and Subscription
-
Coursera 2020 Global Skills Index Highlights Urgent Need for Reskilling
-
New Survey Reveals Only 17% of Employees Give Their Company an Exceptional Employee Experience Rating
-
Complander Launches Product to Help Reduce Pay Inequity
-
Inventiva announces the pricing of its initial public offering on the Nasdaq Global Market
-
Inventiva announces the pricing of its initial public offering on the Nasdaq Global Market
-
Form 3 Nkarta, Inc. For: Jul 09 Filed by: New Enterprise Associates 15, L.P.
-
Aetion and Cegedim Health Data announce new partnership to power real-world evidence research in Europe
-
Aetion and Cegedim Health Data announce new partnership to power real-world evidence research in Europe
-
Form SC 13D/A Liquidia Technologies Filed by: New Enterprise Associates 12, Limited Partnership
-
Form SC 13D Akouos, Inc. Filed by: New Enterprise Associates 16, L.P.
-
Beyond Identity Joins FIDO Alliance
-
Beyond Identity Joins FIDO Alliance
-
CVRx® Raises $50 Million in New Equity Financing
-
OmniSci Powers New Website Enabling Public to View House-by-House Information On Flint Water Crisis
-
Annexon Closes $100 Million Financing to Advance Broad Pipeline of Classical Complement Therapeutics
-
Annexon Closes $100 Million Financing to Advance Broad Pipeline of Classical Complement Therapeutics
-
Jeff Immelt, Former CEO of GE, Joins Built Robotics as an Advisor
-
Location Technology Company InMarket Selects OmniSci To Provide Accelerated Geospatial Analytics for Marketing Clients
-
Duolingo Names Sara Clemens and Amy Bohutinsky to Board of Directors
-
OmniSci Marks Membership in TM Forum, Showcases Early Results with Telecom Industry Leaders Around 5G Business Resiliency
-
OmniSci Marks Membership in TM Forum, Showcases Early Results with Telecom Industry Leaders Around 5G Business Resiliency
-
DataRobot Expands Partnership with Snowflake, Joins Snowflake Partner Connect
-
Gilead Sciences (GILD) will acquire 49.9% equity interest in Pionyr Immunotherapeutic for $275 million
-
Gilead Sciences Secures Exclusive Option to Acquire Pionyr Immunotherapeutics
-
Form 4 AVEO PHARMACEUTICALS, For: Jun 19 Filed by: New Enterprise Associates 15, L.P.
-
Form SC 13D/A ARDELYX, INC. Filed by: New Enterprise Associates 12, Limited Partnership
-
DataRobot Rolls Out Enhancements to Enterprise AI Platform Designed to Drive Greater Business Value from AI
-
CINDE Announces: Coursera and Costa Rica Launch a Joint Program to Strengthen Industry 4.0 Skills and Train - Free of Charge - 50,000 People to Confront the COVID-19 Crisis
-
DataRobot Announces 10x: The Applied Data Science Academy to Expand Education and Access to Jobs in Rapidly Growing Data Science Field
-
Topia Launches Next Generation Global Talent Mobility Platform, Giving Enterprises an Edge in a Competitive, Unpredictable Talent Market
-
Novavax (NVAX) Announces David Mott to Board
-
Novavax Appoints Biotechnology Veteran David Mott to Board of Directors
-
Novavax Appoints Biotechnology Veteran David Mott to Board of Directors
-
Form SC 13D/A Senseonics Holdings, Filed by: NEW ENTERPRISE ASSOCIATES 10 L P
-
CIT GAP Funds Invests in Agrology to Increase the Precision of Agriculture
-
Form 4 ARDELYX, INC. For: Jun 10 Filed by: New Enterprise Associates 12, Limited Partnership
-
DataRobot to Host Inaugural AI Experience Worldwide Conference, “Accelerating the Impact of AI in Changing Times”
-
Skyhook Chooses OmniSci to Support Mobility Indexing In Next Phase of COVID-19 Response
-
DataRobot Acquires Boston Consulting Group’s SOURCE AI Technology, Kicking Off Industry-First Strategic Partnership
-
Affinia Therapeutics Announces Appointment of Elliott Sigal, M.D., Ph.D. to the Company’s Board of Directors
-
Affinia Therapeutics Announces Appointment of Elliott Sigal, M.D., Ph.D. to the Company’s Board of Directors
-
CIT Investment Director Marco Rubin Co-Hosts New Podcast Series for Entrepreneurs
-
Complexa Completes Patient Enrollment in Phase 2 FIRSTx Trial Evaluating CXA-10 in Focal Segmental Glomerulosclerosis, a Rare and Severe Form of Kidney Disease
-
CIT GAP Funds Invests in Scout Inc. to Fundamentally Change the Spaceflight Risk Environment
-
OrphoMed Resumes Recruitment for Phase 2 Adaptive Design Study of ORP-101 for Treatment of IBS-D
-
Lumos Pharma Reports First Quarter 2020 Results and Provides Update on Clinical and Corporate Activities

